Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Immune and acute phase response in pigs experimentally infected with H1N2 swine influenza virus.

Pomorska-Mól M, Markowska-Daniel I, Kwit K.

FEMS Immunol Med Microbiol. 2012 Dec;66(3):334-42. doi: 10.1111/j.1574-695X.2012.01026.x. Epub 2012 Sep 12.

2.

C-reactive protein, haptoglobin, serum amyloid A and pig major acute phase protein response in pigs simultaneously infected with H1N1 swine influenza virus and Pasteurella multocida.

Pomorska-Mól M, Markowska-Daniel I, Kwit K, Stępniewska K, Pejsak Z.

BMC Vet Res. 2013 Jan 18;9:14. doi: 10.1186/1746-6148-9-14.

3.

Acute phase protein response during subclinical infection of pigs with H1N1 swine influenza virus.

Pomorska-Mól M, Markowska-Daniel I, Pejsak Z.

Vet Microbiol. 2012 Oct 12;159(3-4):499-503. doi: 10.1016/j.vetmic.2012.04.030. Epub 2012 Apr 28.

PMID:
22580193
4.

Analysis of the acute-phase protein response in pigs to clinical and subclinical infection with H3N2 swine influenza virus.

Pomorska-Mól M, Kwit K, Pejsak Z, Markowska-Daniel I.

Influenza Other Respir Viruses. 2014 Mar;8(2):228-34.

5.

Immune and inflammatory response in pigs during acute influenza caused by H1N1 swine influenza virus.

Pomorska-Mól M, Markowska-Daniel I, Kwit K, Czyżewska E, Dors A, Rachubik J, Pejsak Z.

Arch Virol. 2014 Oct;159(10):2605-14. doi: 10.1007/s00705-014-2116-1. Epub 2014 May 21.

6.

Pathogenesis and subsequent cross-protection of influenza virus infection in pigs sustained by an H1N2 strain.

Ferrari M, Borghetti P, Foni E, Robotti C, Di Lecce R, Corradi A, Petrini S, Bottarelli E.

Zoonoses Public Health. 2010 Jun;57(4):273-80. doi: 10.1111/j.1863-2378.2009.01239.x. Epub 2009 Jun 17.

PMID:
19538454
7.

Pre-infection of pigs with Mycoplasma hyopneumoniae modifies outcomes of infection with European swine influenza virus of H1N1, but not H1N2, subtype.

Deblanc C, Gorin S, Quéguiner S, Gautier-Bouchardon AV, Ferré S, Amenna N, Cariolet R, Simon G.

Vet Microbiol. 2012 May 25;157(1-2):96-105. doi: 10.1016/j.vetmic.2011.12.027. Epub 2011 Dec 29.

PMID:
22261237
8.

Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vaccine. 2011 Mar 24;29(15):2712-9. doi: 10.1016/j.vaccine.2011.01.082. Epub 2011 Feb 23.

PMID:
21310191
9.

Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.

Platt R, Vincent AL, Gauger PC, Loving CL, Zanella EL, Lager KM, Kehrli ME Jr, Kimura K, Roth JA.

Vet Immunol Immunopathol. 2011 Aug 15;142(3-4):252-7. doi: 10.1016/j.vetimm.2011.05.005. Epub 2011 May 7.

PMID:
21664701
10.

The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL.

Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):117-28. Epub 2006 Apr 18.

PMID:
16621020
11.

Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Henningson JN, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vet Pathol. 2012 Nov;49(6):900-12. doi: 10.1177/0300985812439724. Epub 2012 Mar 28.

PMID:
22461226
12.

Kinetics of the response of four positive acute phase proteins in pigs experimentally infected with toxigenic Pasteurella multocida.

Pomorska-Mól M, Markowska-Daniel I, Kwit K, Stępniewska K, Pejsak Z.

Vet Microbiol. 2011 Sep 28;152(3-4):429-35. doi: 10.1016/j.vetmic.2011.05.032. Epub 2011 May 25.

PMID:
21676559
13.
14.

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.

Van Reeth K, Gregory V, Hay A, Pensaert M.

Vaccine. 2003 Mar 28;21(13-14):1375-81.

PMID:
12615433
15.

Seroprevalence and risk factors of swine influenza in Spain.

Simon-Grifé M, Martín-Valls GE, Vilar MJ, García-Bocanegra I, Mora M, Martín M, Mateu E, Casal J.

Vet Microbiol. 2011 Apr 21;149(1-2):56-63. doi: 10.1016/j.vetmic.2010.10.015. Epub 2010 Nov 4.

PMID:
21112702
16.

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solórzano A, García-Sastre A.

J Virol. 2006 Nov;80(22):11009-18. Epub 2006 Aug 30.

17.

Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.

Masic A, Lu X, Li J, Mutwiri GK, Babiuk LA, Brown EG, Zhou Y.

Vaccine. 2010 Oct 8;28(43):7098-108. doi: 10.1016/j.vaccine.2010.08.003. Epub 2010 Aug 12.

PMID:
20708697
18.

The porcine acute phase protein response to acute clinical and subclinical experimental infection with Streptococcus suis.

Sorensen NS, Tegtmeier C, Andresen LO, Piñeiro M, Toussaint MJ, Campbell FM, Lampreave F, Heegaard PM.

Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):157-68. Epub 2006 Jun 13.

PMID:
16774789
20.

Profile of the porcine acute-phase proteins response following experimental co-infection with H3N2 swine influenza virus and Pasteurella multocida.

Pomorska-Mól M, Markowska-Daniel I, Kwit K, Stępniewska K, Pejsak Z.

Biomarkers. 2015;20(3):189-95. doi: 10.3109/1354750X.2015.1061600. Epub 2015 Jul 13.

PMID:
26161700

Supplemental Content

Support Center